Skip to content
Open access

The peptide Ac2-26 preserves mitochondrial function and neuronal survival in human retinal cells and organoids under hyperglycemic and inflammatory stress.

Aug 2026 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · Vol 203, pp. 119849 · 0 citations · 92 references
Medicine

TL;DR

It is demonstrated that Ac2-26 acts as a pro-resolving neuroprotective agent that targets convergent inflammatory and mitochondrial pathways involved in early diabetic retinal degeneration, highlighting the FPR2-p38-NOX4 axis as a promising therapeutic target for early intervention in diabetic retinopathy.

Abstract

Diabetic retinopathy (DR) is a neurodegenerative disease characterized by hyperglycemia-induced inflammation, mitochondrial dysfunction, and progressive neuronal cell death, leading to irreversible vision loss. Retinal ganglion cells (RGCs) are particularly vulnerable to this hostile microenvironment, undergoing apoptosis before microvascular pathology becomes clinically evident. However, therapeutic strategies targeting these early neurodegenerative events remain limited. Here, we investigated the protective effects of the Annexin A1 mimetic peptide Ac2-26 using complementary human retinal organoid (RO) and organoid-derived retinal ganglion cell (RGC) models of diabetes-like stress. In retinal organoids, Ac2-26 significantly attenuated high glucose-induced retinal degeneration by coordinately suppressing intrinsic and extrinsic apoptotic pathways, reducing Müller cell gliosis, and selectively modulating inflammatory mediators associated with DR progression. In organoid-derived RGCs, Ac2-26 reduced mitochondrial oxidative stress, restored mitochondrial bioenergetics, and prevented neuronal apoptosis under both hyperglycemic and inflammatory conditions. Mechanistically, these protective effects were associated with FPR2-dependent suppression of the p38/NOX4 signaling axis, identifying oxidative stress regulation as a central mechanism underlying mitochondrial preservation. Collectively, our findings demonstrate that Ac2-26 acts as a pro-resolving neuroprotective agent that targets convergent inflammatory and mitochondrial pathways involved in early diabetic retinal degeneration, highlighting the FPR2-p38-NOX4 axis as a promising therapeutic target for early intervention in diabetic retinopathy.

Read PDF

Similar papers

Open access Aug 2026

Physalin A protects against diabetes-like retinal neurodegeneration via autophagy, mitophagy, and antioxidant pathways in Drosophila melanogaster

PA confers neuroretinal protection in DR-like Drosophila by rebalancing apoptosis and autophagy, activating PINK1/parkin-mediated mitophagy, and strengthening antioxidant defenses, culminating in structural preservation and recovery of visual function.

Yan-Ru Xiao, Wei-Yong Lin, Wen-Zhen Lee et al. · 0 citations
Aug 2026

UCHL1 attenuates diabetic retinopathy by deubiquitinating and stabilizing NRF2 to suppress oxidative stress-induced retinal vascular endothelial ferroptosis.

The UCHL1/NRF2 axis may represent a therapeutic target in DR and co-immunoprecipitation and ubiquitination assays demonstrated that UCHL1 interacted with NRF2 and stabilized NRF2 by removing K48-linked polyubiquitin chains.

Sanhua Xu, Jun Huang, Yi-Cang Wang et al. · 0 citations
Open access Sep 2026

Retinal organoid–based evaluation of icariin-loaded extracellular vesicles for hypoxia-induced retinal injury via mitochondrial modulation

Hypoxic injury is a critical pathological factor in various retinal degenerative diseases, leading to mitochondrial dysfunction and irreversible loss of retinal neurons. This study investigated the neuroprotective potential of Icariin-loaded extracellular vesicles (EV_ICA) using both R28 retinal progenitor cells an...

Mira Park, Hyeoun Ji Kim, Y. Go et al. · 0 citations
Sep 2026

Andrographolide-loaded PLGA nanoparticles protect retinal ganglion cells against experimental acute glaucomatous injury and attenuate mitochondrial dysfunction and retinal PANoptosis-related changes.

Developed ADR-loaded poly(lactic-co-glycolic acid) nanoparticles (ADR-NPs) and evaluated their protective effects in oxygen-glucose deprivation/recovery (OGD/R)-injured R28 cells and a rat retinal ischemia/reperfusion (RIR) model protected against experimental acute glaucomatous injury by attenuating oxidative stress,...

Xiao Fan, Ruo-Tong Ouyang, Yu-Jia Huo et al. · 0 citations
Open access Aug 2026

VCP inhibition preserves photoreceptor integrity under hydroquinone-induced oxidative stress in a human iPSC-RPE/porcine neuroretina co-culture model

The iPSC-RPE/neuroretina co-culture is established as a platform to analyse pathophysiological features of AMD, dissect cell type-specific retinal responses to environmental stress and test neuroprotective pharmacological approaches to protect photoreceptors in oxidative stress-associated retinal degeneration.

Ana C. Almansa-Garcia, A. Armento, Shibu Antony et al. · 0 citations
Open access Sep 2026

Targeted Intracellular Metal Modulation Attenuates Oxidative Stress and Preserves Retinal Integrity and Function in a Zebrafish Model of Mitochondrial Dysfunction and Age-Related Retinal Degeneration

Retinal degeneration is associated with mitochondrial dysfunction, oxidative stress, and disruption of metal homeostasis within the retinal pigment epithelium (RPE). Dysregulation of redox-active metals has been implicated in age-related macular degeneration (AMD), but whether targeted intracellular metal modulation pr...

I. Angel, Kalaichitra Periyasamy, Micha Gladnikoff et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.